A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part one: The principles of glucose clamp studies

Glucose clamp studies are used to determine pharmacokinetics (PK) and pharmacodynamics (PD) of analogue insulins. With the development of longer-acting basal analogue insulins, including glargine 300 (Gla-300) and insulin degludec (IDeg), results from numerous glucose clamp studies are readily avail...

Full description

Saved in:
Bibliographic Details
Main Authors: Oppel B.W. Greeff, Jacob John van Tonder, Kershlin Naidu, Alicia McMaster, Alet van Tonder, Rashem Mothilal
Format: Article
Language:English
Published: AOSIS 2018-07-01
Series:South African Family Practice
Subjects:
Online Access:https://safpj.co.za/index.php/safpj/article/view/4874
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849737539616768000
author Oppel B.W. Greeff
Jacob John van Tonder
Kershlin Naidu
Alicia McMaster
Alet van Tonder
Rashem Mothilal
author_facet Oppel B.W. Greeff
Jacob John van Tonder
Kershlin Naidu
Alicia McMaster
Alet van Tonder
Rashem Mothilal
author_sort Oppel B.W. Greeff
collection DOAJ
description Glucose clamp studies are used to determine pharmacokinetics (PK) and pharmacodynamics (PD) of analogue insulins. With the development of longer-acting basal analogue insulins, including glargine 300 (Gla-300) and insulin degludec (IDeg), results from numerous glucose clamp studies are readily available. However, interpreting PK/PD profiles in a scientifically sound manner can be a challenging feat. This is the first in a series of publications that will suggest practical tips for interpreting and comparing results from glucose clamp studies. Variations in the glucose clamp methodology, duration of clamp studies and glucose clamp targets influence the study design and results significantly. Selection of study populations, including healthy patients or patients with Type 1 or 2 diabetes mellitus, has important implications. The dose of study insulin should reflect that of the general treatment population, and ideally steady-state conditions should be used. During the study the plasma insulin concentration and glucose infusion rate describe the pharmacokinetics and pharmacodynamics of the study insulin. With these practical tips in mind, results of glucose clamp studies can be interpreted in a scientifically correct manner. The next article in this series will discuss the interpretation of PK/PD profiles using two newly developed longer-acting basal analogue insulins: Gla-300 and IDeg.
format Article
id doaj-art-d47df1cfb81a45daa864710f39bf33a9
institution DOAJ
issn 2078-6190
2078-6204
language English
publishDate 2018-07-01
publisher AOSIS
record_format Article
series South African Family Practice
spelling doaj-art-d47df1cfb81a45daa864710f39bf33a92025-08-20T03:06:53ZengAOSISSouth African Family Practice2078-61902078-62042018-07-0160381210.4102/safp.v60i3.48743851A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part one: The principles of glucose clamp studiesOppel B.W. Greeff0Jacob John van Tonder1Kershlin Naidu2Alicia McMaster3Alet van Tonder4Rashem Mothilal5University of PretoriaTriclinium Clinical Development (Pty) LtdChris Hani Baragwanath Academic Hospital, University of the WitwatersrandSanofi-Aventis South Africa (Pty) LtdSanofi-Aventis South Africa (Pty) LtdSanofi-Aventis South Africa (Pty) LtdGlucose clamp studies are used to determine pharmacokinetics (PK) and pharmacodynamics (PD) of analogue insulins. With the development of longer-acting basal analogue insulins, including glargine 300 (Gla-300) and insulin degludec (IDeg), results from numerous glucose clamp studies are readily available. However, interpreting PK/PD profiles in a scientifically sound manner can be a challenging feat. This is the first in a series of publications that will suggest practical tips for interpreting and comparing results from glucose clamp studies. Variations in the glucose clamp methodology, duration of clamp studies and glucose clamp targets influence the study design and results significantly. Selection of study populations, including healthy patients or patients with Type 1 or 2 diabetes mellitus, has important implications. The dose of study insulin should reflect that of the general treatment population, and ideally steady-state conditions should be used. During the study the plasma insulin concentration and glucose infusion rate describe the pharmacokinetics and pharmacodynamics of the study insulin. With these practical tips in mind, results of glucose clamp studies can be interpreted in a scientifically correct manner. The next article in this series will discuss the interpretation of PK/PD profiles using two newly developed longer-acting basal analogue insulins: Gla-300 and IDeg.https://safpj.co.za/index.php/safpj/article/view/4874analogue insulinsglucose clamptime–action profileglucose infusion ratepharmacokinetics
spellingShingle Oppel B.W. Greeff
Jacob John van Tonder
Kershlin Naidu
Alicia McMaster
Alet van Tonder
Rashem Mothilal
A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part one: The principles of glucose clamp studies
South African Family Practice
analogue insulins
glucose clamp
time–action profile
glucose infusion rate
pharmacokinetics
title A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part one: The principles of glucose clamp studies
title_full A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part one: The principles of glucose clamp studies
title_fullStr A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part one: The principles of glucose clamp studies
title_full_unstemmed A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part one: The principles of glucose clamp studies
title_short A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part one: The principles of glucose clamp studies
title_sort practical guide to the interpretation of pk pd profiles of longer acting analogue insulins part one the principles of glucose clamp studies
topic analogue insulins
glucose clamp
time–action profile
glucose infusion rate
pharmacokinetics
url https://safpj.co.za/index.php/safpj/article/view/4874
work_keys_str_mv AT oppelbwgreeff apracticalguidetotheinterpretationofpkpdprofilesoflongeractinganalogueinsulinspartonetheprinciplesofglucoseclampstudies
AT jacobjohnvantonder apracticalguidetotheinterpretationofpkpdprofilesoflongeractinganalogueinsulinspartonetheprinciplesofglucoseclampstudies
AT kershlinnaidu apracticalguidetotheinterpretationofpkpdprofilesoflongeractinganalogueinsulinspartonetheprinciplesofglucoseclampstudies
AT aliciamcmaster apracticalguidetotheinterpretationofpkpdprofilesoflongeractinganalogueinsulinspartonetheprinciplesofglucoseclampstudies
AT aletvantonder apracticalguidetotheinterpretationofpkpdprofilesoflongeractinganalogueinsulinspartonetheprinciplesofglucoseclampstudies
AT rashemmothilal apracticalguidetotheinterpretationofpkpdprofilesoflongeractinganalogueinsulinspartonetheprinciplesofglucoseclampstudies
AT oppelbwgreeff practicalguidetotheinterpretationofpkpdprofilesoflongeractinganalogueinsulinspartonetheprinciplesofglucoseclampstudies
AT jacobjohnvantonder practicalguidetotheinterpretationofpkpdprofilesoflongeractinganalogueinsulinspartonetheprinciplesofglucoseclampstudies
AT kershlinnaidu practicalguidetotheinterpretationofpkpdprofilesoflongeractinganalogueinsulinspartonetheprinciplesofglucoseclampstudies
AT aliciamcmaster practicalguidetotheinterpretationofpkpdprofilesoflongeractinganalogueinsulinspartonetheprinciplesofglucoseclampstudies
AT aletvantonder practicalguidetotheinterpretationofpkpdprofilesoflongeractinganalogueinsulinspartonetheprinciplesofglucoseclampstudies
AT rashemmothilal practicalguidetotheinterpretationofpkpdprofilesoflongeractinganalogueinsulinspartonetheprinciplesofglucoseclampstudies